4 hours Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take holdYouTube

Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold.

Coronavirus · Moderna (MRNA)

3 hours Moderna, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

5 hours Moderna reports surprise profit on higher-than-expected COVID vaccine salesYahoo Finance X

5 hours Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing?Investor's Business Daily X

6 hours The Smartest Dividend Stock to Buy With $10,000 Right NowThe Motley Fool X

6 hours These Stocks Are Moving the Most Today: Qualcomm, DJT, Arm, Moderna, SolarEdge, Lyft, Zillow, AppLovin, Wolfspeed, and MoreYahoo Finance X

19 hours Gilead Sciences Rides Covid Treatment To Another Beat And RaiseInvestor's Business Daily X

19 hours Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidanceMarketWatch X

2 days How to Buy Moderna (MRNA) StockBenzinga X

2 days Nintendo is struggling to sell a product that was once sold outTheStreet X

2 days Moderna CEO Bancel steps down as sales chief, Bloomberg News reportsInvesting.com X

2 days UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US StocksInsider Monkey X

3 days Goldman Sachs sees rate cuts, but elections make things tricky for 2025TheStreet X

3 days AMC’s third-quarter results on deck amid signs of a cinema-industry reboundMarketWatch X

3 days Arcturus Gears Up to Report Q3 Earnings: Here’s What to ExpectZacks X

3 days TGI Fridays bankruptcy update: Will more restaurant locations close amid Chapter 11?Fast Company X

3 days OraSure: An NCAV Diamond In The COVID RoughSeeking Alpha X

5 days TGI Fridays files for bankruptcy, as sit-down chain restaurants face challengesCBS News X

6 days This Idaho Health Department Has Stopped Providing COVID-19 VaccinesInc.com X

7 days Moderna (MRNA) Stock Moves -0.66%: What You Should KnowZacks X

7 days Moderna (MRNA): Expanding Horizons in Gene Editing and mRNA VaccinesInsider Monkey X

1 week COVID-19 is no longer the world’s leading infectious disease killerFortune X

1 week Is Moderna, Inc. (MRNA) The Worst Performing S&P 500 Stock In 2024?Insider Monkey X

1 week VW’s Profitability Is the Lowest Since the Covid-19 PandemicYouTube X

1 week Jefferies’ Top Crowded Semiconductor Long Positions: Top 10 StocksInsider Monkey X

1 week Moderna (MRNA) Exceeds Market Returns: Some Facts to ConsiderZacks X

1 week Moderna (NASDAQ:MRNA) Stock Price Up 3.9% – What’s Next?MarketBeat X

1 week Pfizer profit up on COVID treatment sales as it faces activist pressureInvesting.com X

1 week BP beats forecasts despite seeing 31% drop in profits, to lowest since COVID-19MarketWatch X

1 week Will Non-COVID Drugs Again Boost Pfizer’s Top Line in Q3 Earnings?Zacks X

1 week Moderna Stock Price Target Slashed. It’s About Vaccines.Yahoo Finance X

2 weeks On Navajo Nation, a push to electrify more homes on the vast reservationMarketBeat X

2 weeks Joseph Gagnon On The Trinity Of COVID-Era Inflation And The Upcoming Fed Framework ReviewSeeking Alpha X

2 weeks AptarGroup CEO: Consumer is still there, but our numbers reflect inventory adjustments post-COVIDYouTube X

2 weeks 10 Best Airline Stocks to Buy According to Hedge FundsInsider Monkey X

2 weeks UBS Group Trims Moderna (NASDAQ:MRNA) Target Price to $108.00MarketBeat X

2 weeks This company redesigned the underwire bra to actually be comfortableFast Company X

2 weeks Las Vegas Sands misses Q3 estimates with visitation to Macao below pre-COVID levelsInvesting.com X

2 weeks Moderna, Inc. (MRNA): Leading the Way in mRNA Vaccines and Respiratory HealthInsider Monkey X

2 weeks The Best Pharmaceutical Stock to Invest $1,000 in Right NowThe Motley Fool X

2 weeks We Think Moderna Still Has A FutureSeeking Alpha X

2 weeks Pneumonia can be a deadly complication of COVID, the flu, and RSV: What to know about pneumococcal vaccinationFortune X

2 weeks Moderna: Assessing The Impact Of GSK’s Patent LawsuitSeeking Alpha X

2 weeks Why Moderna (MRNA) Dipped More Than Broader Market TodayZacks X

2 weeks EPR Properties Rebounds: Here’s How to Cash In on a 7% YieldInvestors Alley X

3 weeks Southwest’s Lead From COVID Has Dissipated, And Now They Face The ConsequencesSeeking Alpha X

3 weeks How Bad Is This News for Novavax?The Motley Fool X

3 weeks mRNA licensing agreements surge 800% amid GSK lawsuitsYahoo Finance X

3 weeks 3 Invesco Mutual Funds That Deserve Your AttentionZacks X

3 weeks Vontobel Holding Ltd. Grows Position in Moderna, Inc. (NASDAQ:MRNA)MarketBeat X

3 weeks Want to Understand America? Watch ‘Shark Tank.’The New York Times X